Dr. Mark E. Burkard

Dr. Mark E. Burkard, MD, PhD, is a highly regarded medical oncologist and physician–scientist specializing in breast cancer. He serves as the Director of the University of Iowa Holden Comprehensive Cancer Center, an NCI-designated comprehensive cancer center, and holds the C.E. Block Chair of Cancer Research. He previously served as Professor of Medicine at the University of Wisconsin School of Medicine and Public Health and was a member of the UW Carbone Cancer Center. Dr. Burkard earned his MD and PhD from the University of Rochester, completed residency training in internal medicine at New York Hospital/Weill Cornell, and pursued fellowship training in medical oncology at Memorial Sloan Kettering Cancer Center. He is board-certified in Internal Medicine and Medical Oncology and is recognized for his expertise in translational breast oncology research.

Dr. Burkard’s research program has focused on understanding genomic instability in cancer, with an emphasis on the mechanisms of chromosomal segregation and their therapeutic implications. His work has led to the development of targeted approaches in breast cancer and contributed to clinical trials integrating novel agents into precision oncology. He has authored numerous peer-reviewed publications supported by NIH funding and has collaborated across institutions to advance data science and improve clinical trial access, including efforts to address disparities in rural cancer care. His scholarship has influenced national perspectives on the biology and treatment of breast cancer.

Alongside his clinical and research activities, Dr. Burkard is a committed educator and mentor. He has trained medical students, residents, fellows, and junior faculty in both clinical and laboratory settings and is admired for his supportive and rigorous approach to mentorship. He has served on NIH review panels, contributed to cooperative group leadership, and played a role in shaping institutional programs in precision oncology. Through his contributions to research, education, and leadership, Dr. Mark Burkard continues to advance the science and delivery of breast cancer care.